ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Potent Adjuvantic Activity of a CCR1-agonistic Bis-Quinoline
dc.contributor.author | Ukani, Rehman | |
dc.contributor.author | Lewis, Tyler C. | |
dc.contributor.author | Day, Timothy P. | |
dc.contributor.author | Wu, Wenyan | |
dc.contributor.author | Malladi, Subbalakshmi S. | |
dc.contributor.author | Warshakoon, Hemamali J. | |
dc.contributor.author | David, Sunil A. | |
dc.date.accessioned | 2017-05-04T18:14:09Z | |
dc.date.available | 2017-05-04T18:14:09Z | |
dc.date.issued | 2012-01-01 | |
dc.identifier.citation | Ukani, R., Lewis, T. C., Day, T. P., Wu, W., Malladi, S. S., Warshakoon, H. J., & David, S. A. (2012). Potent Adjuvantic Activity of a CCR1-agonistic Bis-Quinoline. Bioorganic & Medicinal Chemistry Letters, 22(1), 293–295. http://doi.org/10.1016/j.bmcl.2011.11.014 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/23892 | |
dc.description.abstract | A bis-quinoline compound, (7-chloro-N-(4-(7-chloroquinolin-4-ylamino)butyl)quinolin-4-amine; RE-660) was found to have C-C chemokine receptor type 1 (CCR1)-agonistic properties.RE-660 displayed strong adjuvantic activity in mice when co-administered with bovine α-lactalbumin used as a model subunit protein antigen. RE-660 evoked a balanced Th1 (IgG2)/Th2 (IgG1) antibody profile, and the quality of antibodies elicited by the bis-quinoline was found to be superior to that evoked by glucopyranosyl lipid A by surface plasmon resonance experiments. No evidence of proinflammatory activity was observed in human blood ex vivo models. In preliminary acute toxicity studies, the compound was found to be of lower toxicity than chloroquine in mice, and was non-mutagenic in an Ames screen. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This article is made available under an Attribution-NonCommercial-NoDerivs 3.0 United States (CC BY-NC-ND 3.0 US) License. | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/us/ | en_US |
dc.subject | Vaccines | en_US |
dc.subject | Adjuvants | en_US |
dc.subject | Bis-quinolines | en_US |
dc.subject | CCR1 | en_US |
dc.subject | Cytokines | en_US |
dc.title | Potent Adjuvantic Activity of a CCR1-agonistic Bis-Quinoline | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Ukani, Rehman | |
kusw.kuauthor | Lewis, Tyler C. | |
kusw.kuauthor | Day, Timothy P. | |
kusw.kuauthor | Wu, Wenyan | |
kusw.kuauthor | Malladi, Subbalakshmi S. | |
kusw.kuauthor | Warshakoon, Hemamali J. | |
kusw.kuauthor | David, Sunil A. | |
kusw.kudepartment | Medicinal Chemistry | en_US |
dc.identifier.doi | 10.1016/j.bmcl.2011.11.014 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0003-2197-1917 | |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC3248955 | en_US |
dc.rights.accessrights | openAccess |